Concepedia

Nadav Wallis

NW

Statistics

Publications

3

Citations

117

H-Index

3

Active since

2021

Affiliations

Penn State Milton S. Hershey Medical Center(Current)

University College London

Pennsylvania State University

Institute of Structural and Molecular Biology

Hebrew University of Jerusalem

Nadav Wallis is an author at Penn State Milton S. Hershey Medical Center specializing in cancer cell signaling, targeted cancer therapy, and molecular oncology.

ORCID

Publications per year

2021–2025

3

Publications

3

Small molecule inhibitor of Igf2bp1 represses Kras and a pro-oncogenic phenotype in cancer cells

Nadav Wallis, Froma Oberman, Khriesto A. Shurrush et al. · RNA Biology · 2021 · 71 citations · Full text

, , +17

Development of a specific and potent IGF2BP1 inhibitor: A promising therapeutic agent for IGF2BP1-expressing cancers

Amandeep Singh, Vikash Singh, Nadav Wallis et al. · European Journal of Medicinal Chemistry · 2023 · 26 citations · Full text

, , +11

Phenylpyrazoles as Inhibitors of the m<sup>6</sup>A RNA-Binding Protein YTHDF2

Xiaqiu Qiu, Claus Kemker, Georg L. Goebel et al. · JACS Au · 2025 · 20 citations · Full text

, , +12

1–3 of 3